nodes	percent_of_prediction	percent_of_DWPC	metapath
Dipyridamole—PDE4A—chronic obstructive pulmonary disease	0.369	1	CbGaD
Dipyridamole—PDE4A—Roflumilast—chronic obstructive pulmonary disease	0.179	0.458	CbGbCtD
Dipyridamole—PDE3A—Aminophylline—chronic obstructive pulmonary disease	0.103	0.264	CbGbCtD
Dipyridamole—PDE4A—Aminophylline—chronic obstructive pulmonary disease	0.0982	0.251	CbGbCtD
Dipyridamole—ADA—pleura—chronic obstructive pulmonary disease	0.00996	0.167	CbGeAlD
Dipyridamole—PDE8B—leg—chronic obstructive pulmonary disease	0.00538	0.09	CbGeAlD
Dipyridamole—ABCB1—Prednisolone—chronic obstructive pulmonary disease	0.00532	0.0136	CbGbCtD
Dipyridamole—ABCB1—Prednisone—chronic obstructive pulmonary disease	0.00503	0.0129	CbGbCtD
Dipyridamole—PDE5A—pulmonary artery—chronic obstructive pulmonary disease	0.00488	0.0815	CbGeAlD
Dipyridamole—PDE6B—respiratory system—chronic obstructive pulmonary disease	0.00232	0.0388	CbGeAlD
Dipyridamole—PDE6B—connective tissue—chronic obstructive pulmonary disease	0.00204	0.0341	CbGeAlD
Dipyridamole—PRUNE—bronchus—chronic obstructive pulmonary disease	0.00201	0.0336	CbGeAlD
Dipyridamole—PDE6D—bronchus—chronic obstructive pulmonary disease	0.00194	0.0324	CbGeAlD
Dipyridamole—PDE1C—lung—chronic obstructive pulmonary disease	0.00144	0.024	CbGeAlD
Dipyridamole—PDE10A—respiratory system—chronic obstructive pulmonary disease	0.0014	0.0234	CbGeAlD
Dipyridamole—PRUNE—lung—chronic obstructive pulmonary disease	0.0013	0.0217	CbGeAlD
Dipyridamole—PDE6D—lung—chronic obstructive pulmonary disease	0.00125	0.0209	CbGeAlD
Dipyridamole—PDE6B—lung—chronic obstructive pulmonary disease	0.00123	0.0206	CbGeAlD
Dipyridamole—PDE3B—connective tissue—chronic obstructive pulmonary disease	0.00115	0.0192	CbGeAlD
Dipyridamole—PDE6G—lung—chronic obstructive pulmonary disease	0.0011	0.0184	CbGeAlD
Dipyridamole—PDE8B—bronchus—chronic obstructive pulmonary disease	0.0011	0.0184	CbGeAlD
Dipyridamole—PDE2A—trachea—chronic obstructive pulmonary disease	0.00104	0.0173	CbGeAlD
Dipyridamole—PDE8A—bronchus—chronic obstructive pulmonary disease	0.00099	0.0165	CbGeAlD
Dipyridamole—ADA—respiratory system—chronic obstructive pulmonary disease	0.00099	0.0165	CbGeAlD
Dipyridamole—PDE8A—smooth muscle tissue—chronic obstructive pulmonary disease	0.000968	0.0162	CbGeAlD
Dipyridamole—PDE1A—smooth muscle tissue—chronic obstructive pulmonary disease	0.000937	0.0157	CbGeAlD
Dipyridamole—PDE7B—lung—chronic obstructive pulmonary disease	0.000892	0.0149	CbGeAlD
Dipyridamole—PDE8A—trachea—chronic obstructive pulmonary disease	0.000889	0.0149	CbGeAlD
Dipyridamole—ADA—connective tissue—chronic obstructive pulmonary disease	0.000871	0.0146	CbGeAlD
Dipyridamole—PDE5A—respiratory system—chronic obstructive pulmonary disease	0.00082	0.0137	CbGeAlD
Dipyridamole—PDE2A—lung—chronic obstructive pulmonary disease	0.000744	0.0124	CbGeAlD
Dipyridamole—PDE10A—lung—chronic obstructive pulmonary disease	0.000744	0.0124	CbGeAlD
Dipyridamole—PDE5A—connective tissue—chronic obstructive pulmonary disease	0.000722	0.0121	CbGeAlD
Dipyridamole—PDE8B—lung—chronic obstructive pulmonary disease	0.00071	0.0119	CbGeAlD
Dipyridamole—PDE3B—lung—chronic obstructive pulmonary disease	0.000693	0.0116	CbGeAlD
Dipyridamole—SLC29A1—respiratory system—chronic obstructive pulmonary disease	0.000689	0.0115	CbGeAlD
Dipyridamole—PDE5A—smooth muscle tissue—chronic obstructive pulmonary disease	0.00066	0.011	CbGeAlD
Dipyridamole—PDE3A—smooth muscle tissue—chronic obstructive pulmonary disease	0.000642	0.0107	CbGeAlD
Dipyridamole—PDE8A—lung—chronic obstructive pulmonary disease	0.000639	0.0107	CbGeAlD
Dipyridamole—PDE1A—lung—chronic obstructive pulmonary disease	0.000618	0.0103	CbGeAlD
Dipyridamole—ABCC5—bronchus—chronic obstructive pulmonary disease	0.000617	0.0103	CbGeAlD
Dipyridamole—SLC29A1—connective tissue—chronic obstructive pulmonary disease	0.000606	0.0101	CbGeAlD
Dipyridamole—SLC29A1—bronchus—chronic obstructive pulmonary disease	0.000567	0.00947	CbGeAlD
Dipyridamole—ADA—lung—chronic obstructive pulmonary disease	0.000525	0.00878	CbGeAlD
Dipyridamole—PDE4A—lung—chronic obstructive pulmonary disease	0.000512	0.00856	CbGeAlD
Dipyridamole—SLC29A1—trachea—chronic obstructive pulmonary disease	0.000509	0.00851	CbGeAlD
Dipyridamole—PDE5A—lung—chronic obstructive pulmonary disease	0.000435	0.00728	CbGeAlD
Dipyridamole—ABCC4—bronchus—chronic obstructive pulmonary disease	0.000428	0.00715	CbGeAlD
Dipyridamole—PDE3A—lung—chronic obstructive pulmonary disease	0.000424	0.00708	CbGeAlD
Dipyridamole—ABCC5—lung—chronic obstructive pulmonary disease	0.000398	0.00666	CbGeAlD
Dipyridamole—SLC29A1—lung—chronic obstructive pulmonary disease	0.000366	0.00611	CbGeAlD
Dipyridamole—ABCC4—lung—chronic obstructive pulmonary disease	0.000276	0.00461	CbGeAlD
Dipyridamole—ABCB1—respiratory system—chronic obstructive pulmonary disease	0.000181	0.00303	CbGeAlD
Dipyridamole—Cardiac arrest—Prednisolone—chronic obstructive pulmonary disease	0.000166	0.00148	CcSEcCtD
Dipyridamole—Cough—Montelukast—chronic obstructive pulmonary disease	0.000166	0.00148	CcSEcCtD
Dipyridamole—Urticaria—Aminophylline—chronic obstructive pulmonary disease	0.000165	0.00147	CcSEcCtD
Dipyridamole—Malaise—Salbutamol—chronic obstructive pulmonary disease	0.000165	0.00147	CcSEcCtD
Dipyridamole—Myalgia—Formoterol—chronic obstructive pulmonary disease	0.000165	0.00147	CcSEcCtD
Dipyridamole—Arthralgia—Arformoterol—chronic obstructive pulmonary disease	0.000165	0.00147	CcSEcCtD
Dipyridamole—Arthralgia—Formoterol—chronic obstructive pulmonary disease	0.000165	0.00147	CcSEcCtD
Dipyridamole—Myalgia—Arformoterol—chronic obstructive pulmonary disease	0.000165	0.00147	CcSEcCtD
Dipyridamole—Chest pain—Formoterol—chronic obstructive pulmonary disease	0.000165	0.00147	CcSEcCtD
Dipyridamole—Chest pain—Arformoterol—chronic obstructive pulmonary disease	0.000165	0.00147	CcSEcCtD
Dipyridamole—Convulsion—Montelukast—chronic obstructive pulmonary disease	0.000164	0.00147	CcSEcCtD
Dipyridamole—Anxiety—Formoterol—chronic obstructive pulmonary disease	0.000164	0.00147	CcSEcCtD
Dipyridamole—Anxiety—Arformoterol—chronic obstructive pulmonary disease	0.000164	0.00147	CcSEcCtD
Dipyridamole—Vertigo—Salbutamol—chronic obstructive pulmonary disease	0.000164	0.00147	CcSEcCtD
Dipyridamole—Abdominal pain—Aminophylline—chronic obstructive pulmonary disease	0.000164	0.00146	CcSEcCtD
Dipyridamole—Syncope—Salbutamol—chronic obstructive pulmonary disease	0.000164	0.00146	CcSEcCtD
Dipyridamole—Unspecified disorder of skin and subcutaneous tissue—Arformoterol—chronic obstructive pulmonary disease	0.000164	0.00146	CcSEcCtD
Dipyridamole—Unspecified disorder of skin and subcutaneous tissue—Formoterol—chronic obstructive pulmonary disease	0.000164	0.00146	CcSEcCtD
Dipyridamole—Discomfort—Formoterol—chronic obstructive pulmonary disease	0.000163	0.00145	CcSEcCtD
Dipyridamole—Discomfort—Arformoterol—chronic obstructive pulmonary disease	0.000163	0.00145	CcSEcCtD
Dipyridamole—Palpitations—Salbutamol—chronic obstructive pulmonary disease	0.000162	0.00144	CcSEcCtD
Dipyridamole—Arthralgia—Montelukast—chronic obstructive pulmonary disease	0.000162	0.00144	CcSEcCtD
Dipyridamole—Myalgia—Montelukast—chronic obstructive pulmonary disease	0.000162	0.00144	CcSEcCtD
Dipyridamole—Dry mouth—Arformoterol—chronic obstructive pulmonary disease	0.000161	0.00144	CcSEcCtD
Dipyridamole—Dry mouth—Formoterol—chronic obstructive pulmonary disease	0.000161	0.00144	CcSEcCtD
Dipyridamole—Anxiety—Montelukast—chronic obstructive pulmonary disease	0.000161	0.00144	CcSEcCtD
Dipyridamole—Loss of consciousness—Salbutamol—chronic obstructive pulmonary disease	0.000161	0.00143	CcSEcCtD
Dipyridamole—Unspecified disorder of skin and subcutaneous tissue—Montelukast—chronic obstructive pulmonary disease	0.00016	0.00143	CcSEcCtD
Dipyridamole—Gastrointestinal pain—Tiotropium—chronic obstructive pulmonary disease	0.00016	0.00143	CcSEcCtD
Dipyridamole—Cough—Salbutamol—chronic obstructive pulmonary disease	0.00016	0.00142	CcSEcCtD
Dipyridamole—Anaphylactic shock—Arformoterol—chronic obstructive pulmonary disease	0.000158	0.00141	CcSEcCtD
Dipyridamole—Anaphylactic shock—Formoterol—chronic obstructive pulmonary disease	0.000158	0.00141	CcSEcCtD
Dipyridamole—Oedema—Arformoterol—chronic obstructive pulmonary disease	0.000158	0.00141	CcSEcCtD
Dipyridamole—Oedema—Formoterol—chronic obstructive pulmonary disease	0.000158	0.00141	CcSEcCtD
Dipyridamole—Hypertension—Salbutamol—chronic obstructive pulmonary disease	0.000158	0.00141	CcSEcCtD
Dipyridamole—Myalgia—Salbutamol—chronic obstructive pulmonary disease	0.000156	0.00139	CcSEcCtD
Dipyridamole—Arthralgia—Salbutamol—chronic obstructive pulmonary disease	0.000156	0.00139	CcSEcCtD
Dipyridamole—Chest pain—Salbutamol—chronic obstructive pulmonary disease	0.000156	0.00139	CcSEcCtD
Dipyridamole—Urticaria—Tiotropium—chronic obstructive pulmonary disease	0.000156	0.00139	CcSEcCtD
Dipyridamole—Pulmonary oedema—Prednisone—chronic obstructive pulmonary disease	0.000155	0.00138	CcSEcCtD
Dipyridamole—Anxiety—Salbutamol—chronic obstructive pulmonary disease	0.000155	0.00138	CcSEcCtD
Dipyridamole—Nervous system disorder—Arformoterol—chronic obstructive pulmonary disease	0.000155	0.00138	CcSEcCtD
Dipyridamole—Nervous system disorder—Formoterol—chronic obstructive pulmonary disease	0.000155	0.00138	CcSEcCtD
Dipyridamole—Abdominal pain—Tiotropium—chronic obstructive pulmonary disease	0.000155	0.00138	CcSEcCtD
Dipyridamole—Oedema—Montelukast—chronic obstructive pulmonary disease	0.000155	0.00138	CcSEcCtD
Dipyridamole—Anaphylactic shock—Montelukast—chronic obstructive pulmonary disease	0.000155	0.00138	CcSEcCtD
Dipyridamole—Tachycardia—Formoterol—chronic obstructive pulmonary disease	0.000154	0.00138	CcSEcCtD
Dipyridamole—Tachycardia—Arformoterol—chronic obstructive pulmonary disease	0.000154	0.00138	CcSEcCtD
Dipyridamole—Discomfort—Salbutamol—chronic obstructive pulmonary disease	0.000154	0.00137	CcSEcCtD
Dipyridamole—Skin disorder—Arformoterol—chronic obstructive pulmonary disease	0.000154	0.00137	CcSEcCtD
Dipyridamole—Skin disorder—Formoterol—chronic obstructive pulmonary disease	0.000154	0.00137	CcSEcCtD
Dipyridamole—Hypersensitivity—Aminophylline—chronic obstructive pulmonary disease	0.000153	0.00136	CcSEcCtD
Dipyridamole—Dry mouth—Salbutamol—chronic obstructive pulmonary disease	0.000152	0.00136	CcSEcCtD
Dipyridamole—Nervous system disorder—Montelukast—chronic obstructive pulmonary disease	0.000152	0.00135	CcSEcCtD
Dipyridamole—Thrombocytopenia—Montelukast—chronic obstructive pulmonary disease	0.000152	0.00135	CcSEcCtD
Dipyridamole—Skin disorder—Montelukast—chronic obstructive pulmonary disease	0.00015	0.00134	CcSEcCtD
Dipyridamole—Oedema—Salbutamol—chronic obstructive pulmonary disease	0.000149	0.00133	CcSEcCtD
Dipyridamole—Anaphylactic shock—Salbutamol—chronic obstructive pulmonary disease	0.000149	0.00133	CcSEcCtD
Dipyridamole—Hypotension—Formoterol—chronic obstructive pulmonary disease	0.000148	0.00132	CcSEcCtD
Dipyridamole—Hypotension—Arformoterol—chronic obstructive pulmonary disease	0.000148	0.00132	CcSEcCtD
Dipyridamole—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.000147	0.00131	CcSEcCtD
Dipyridamole—Shock—Salbutamol—chronic obstructive pulmonary disease	0.000147	0.00131	CcSEcCtD
Dipyridamole—Sweating increased—Prednisolone—chronic obstructive pulmonary disease	0.000147	0.00131	CcSEcCtD
Dipyridamole—Nervous system disorder—Salbutamol—chronic obstructive pulmonary disease	0.000146	0.00131	CcSEcCtD
Dipyridamole—Tachycardia—Salbutamol—chronic obstructive pulmonary disease	0.000146	0.0013	CcSEcCtD
Dipyridamole—Skin disorder—Salbutamol—chronic obstructive pulmonary disease	0.000145	0.00129	CcSEcCtD
Dipyridamole—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	0.000144	0.00129	CcSEcCtD
Dipyridamole—Hyperhidrosis—Salbutamol—chronic obstructive pulmonary disease	0.000144	0.00129	CcSEcCtD
Dipyridamole—Musculoskeletal discomfort—Formoterol—chronic obstructive pulmonary disease	0.000144	0.00128	CcSEcCtD
Dipyridamole—Musculoskeletal discomfort—Arformoterol—chronic obstructive pulmonary disease	0.000144	0.00128	CcSEcCtD
Dipyridamole—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.000142	0.00127	CcSEcCtD
Dipyridamole—Musculoskeletal discomfort—Montelukast—chronic obstructive pulmonary disease	0.000141	0.00126	CcSEcCtD
Dipyridamole—Dyspnoea—Arformoterol—chronic obstructive pulmonary disease	0.000141	0.00126	CcSEcCtD
Dipyridamole—Dyspnoea—Formoterol—chronic obstructive pulmonary disease	0.000141	0.00126	CcSEcCtD
Dipyridamole—Somnolence—Formoterol—chronic obstructive pulmonary disease	0.000141	0.00125	CcSEcCtD
Dipyridamole—Somnolence—Arformoterol—chronic obstructive pulmonary disease	0.000141	0.00125	CcSEcCtD
Dipyridamole—Hypotension—Salbutamol—chronic obstructive pulmonary disease	0.000139	0.00124	CcSEcCtD
Dipyridamole—Dyspepsia—Arformoterol—chronic obstructive pulmonary disease	0.000139	0.00124	CcSEcCtD
Dipyridamole—Dyspepsia—Formoterol—chronic obstructive pulmonary disease	0.000139	0.00124	CcSEcCtD
Dipyridamole—Paraesthesia—Montelukast—chronic obstructive pulmonary disease	0.000139	0.00124	CcSEcCtD
Dipyridamole—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.000139	0.00124	CcSEcCtD
Dipyridamole—Somnolence—Montelukast—chronic obstructive pulmonary disease	0.000138	0.00123	CcSEcCtD
Dipyridamole—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.000137	0.00122	CcSEcCtD
Dipyridamole—Gastrointestinal disorder—Arformoterol—chronic obstructive pulmonary disease	0.000136	0.00122	CcSEcCtD
Dipyridamole—Gastrointestinal disorder—Formoterol—chronic obstructive pulmonary disease	0.000136	0.00122	CcSEcCtD
Dipyridamole—Dyspepsia—Montelukast—chronic obstructive pulmonary disease	0.000136	0.00122	CcSEcCtD
Dipyridamole—Fatigue—Arformoterol—chronic obstructive pulmonary disease	0.000136	0.00122	CcSEcCtD
Dipyridamole—Fatigue—Formoterol—chronic obstructive pulmonary disease	0.000136	0.00122	CcSEcCtD
Dipyridamole—Musculoskeletal discomfort—Salbutamol—chronic obstructive pulmonary disease	0.000136	0.00121	CcSEcCtD
Dipyridamole—Pain—Formoterol—chronic obstructive pulmonary disease	0.000135	0.00121	CcSEcCtD
Dipyridamole—Pain—Arformoterol—chronic obstructive pulmonary disease	0.000135	0.00121	CcSEcCtD
Dipyridamole—Increased appetite—Prednisone—chronic obstructive pulmonary disease	0.000135	0.0012	CcSEcCtD
Dipyridamole—Paraesthesia—Salbutamol—chronic obstructive pulmonary disease	0.000134	0.0012	CcSEcCtD
Dipyridamole—ABCB1—trachea—chronic obstructive pulmonary disease	0.000134	0.00224	CbGeAlD
Dipyridamole—Gastrointestinal disorder—Montelukast—chronic obstructive pulmonary disease	0.000134	0.00119	CcSEcCtD
Dipyridamole—Fatigue—Montelukast—chronic obstructive pulmonary disease	0.000134	0.00119	CcSEcCtD
Dipyridamole—Dyspnoea—Salbutamol—chronic obstructive pulmonary disease	0.000133	0.00119	CcSEcCtD
Dipyridamole—Somnolence—Salbutamol—chronic obstructive pulmonary disease	0.000133	0.00118	CcSEcCtD
Dipyridamole—Pain—Montelukast—chronic obstructive pulmonary disease	0.000132	0.00118	CcSEcCtD
Dipyridamole—Acute coronary syndrome—Prednisolone—chronic obstructive pulmonary disease	0.000132	0.00118	CcSEcCtD
Dipyridamole—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.000132	0.00118	CcSEcCtD
Dipyridamole—Myocardial infarction—Prednisolone—chronic obstructive pulmonary disease	0.000132	0.00117	CcSEcCtD
Dipyridamole—Dyspepsia—Salbutamol—chronic obstructive pulmonary disease	0.000131	0.00117	CcSEcCtD
Dipyridamole—Rash—Aminophylline—chronic obstructive pulmonary disease	0.000131	0.00117	CcSEcCtD
Dipyridamole—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.000131	0.00117	CcSEcCtD
Dipyridamole—Feeling abnormal—Formoterol—chronic obstructive pulmonary disease	0.00013	0.00116	CcSEcCtD
Dipyridamole—Feeling abnormal—Arformoterol—chronic obstructive pulmonary disease	0.00013	0.00116	CcSEcCtD
Dipyridamole—Headache—Aminophylline—chronic obstructive pulmonary disease	0.00013	0.00116	CcSEcCtD
Dipyridamole—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.00013	0.00115	CcSEcCtD
Dipyridamole—Gastrointestinal pain—Formoterol—chronic obstructive pulmonary disease	0.000129	0.00115	CcSEcCtD
Dipyridamole—Gastrointestinal pain—Arformoterol—chronic obstructive pulmonary disease	0.000129	0.00115	CcSEcCtD
Dipyridamole—Gastrointestinal disorder—Salbutamol—chronic obstructive pulmonary disease	0.000129	0.00115	CcSEcCtD
Dipyridamole—Fatigue—Salbutamol—chronic obstructive pulmonary disease	0.000129	0.00115	CcSEcCtD
Dipyridamole—Pain—Salbutamol—chronic obstructive pulmonary disease	0.000128	0.00114	CcSEcCtD
Dipyridamole—Gastrointestinal pain—Montelukast—chronic obstructive pulmonary disease	0.000127	0.00113	CcSEcCtD
Dipyridamole—Gastrointestinal haemorrhage—Prednisone—chronic obstructive pulmonary disease	0.000127	0.00113	CcSEcCtD
Dipyridamole—Urticaria—Formoterol—chronic obstructive pulmonary disease	0.000126	0.00112	CcSEcCtD
Dipyridamole—Urticaria—Arformoterol—chronic obstructive pulmonary disease	0.000126	0.00112	CcSEcCtD
Dipyridamole—Abdominal pain—Arformoterol—chronic obstructive pulmonary disease	0.000125	0.00111	CcSEcCtD
Dipyridamole—Abdominal pain—Formoterol—chronic obstructive pulmonary disease	0.000125	0.00111	CcSEcCtD
Dipyridamole—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.000125	0.00111	CcSEcCtD
Dipyridamole—Rash—Tiotropium—chronic obstructive pulmonary disease	0.000124	0.0011	CcSEcCtD
Dipyridamole—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.000123	0.0011	CcSEcCtD
Dipyridamole—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.000123	0.0011	CcSEcCtD
Dipyridamole—Urticaria—Montelukast—chronic obstructive pulmonary disease	0.000123	0.0011	CcSEcCtD
Dipyridamole—Feeling abnormal—Salbutamol—chronic obstructive pulmonary disease	0.000123	0.0011	CcSEcCtD
Dipyridamole—Headache—Tiotropium—chronic obstructive pulmonary disease	0.000123	0.00109	CcSEcCtD
Dipyridamole—Bradycardia—Prednisolone—chronic obstructive pulmonary disease	0.000123	0.00109	CcSEcCtD
Dipyridamole—Abdominal pain—Montelukast—chronic obstructive pulmonary disease	0.000122	0.00109	CcSEcCtD
Dipyridamole—Gastrointestinal pain—Salbutamol—chronic obstructive pulmonary disease	0.000122	0.00109	CcSEcCtD
Dipyridamole—Haemoglobin—Prednisolone—chronic obstructive pulmonary disease	0.000121	0.00108	CcSEcCtD
Dipyridamole—Haemorrhage—Prednisolone—chronic obstructive pulmonary disease	0.000121	0.00107	CcSEcCtD
Dipyridamole—Cardiac arrest—Prednisone—chronic obstructive pulmonary disease	0.00012	0.00107	CcSEcCtD
Dipyridamole—Urticaria—Salbutamol—chronic obstructive pulmonary disease	0.000119	0.00106	CcSEcCtD
Dipyridamole—Abdominal pain—Salbutamol—chronic obstructive pulmonary disease	0.000118	0.00105	CcSEcCtD
Dipyridamole—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	0.000116	0.00104	CcSEcCtD
Dipyridamole—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	0.000116	0.00104	CcSEcCtD
Dipyridamole—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.000116	0.00104	CcSEcCtD
Dipyridamole—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	0.000114	0.00102	CcSEcCtD
Dipyridamole—Asthenia—Formoterol—chronic obstructive pulmonary disease	0.000113	0.00101	CcSEcCtD
Dipyridamole—Asthenia—Arformoterol—chronic obstructive pulmonary disease	0.000113	0.00101	CcSEcCtD
Dipyridamole—Pruritus—Arformoterol—chronic obstructive pulmonary disease	0.000112	0.000997	CcSEcCtD
Dipyridamole—Pruritus—Formoterol—chronic obstructive pulmonary disease	0.000112	0.000997	CcSEcCtD
Dipyridamole—Asthenia—Montelukast—chronic obstructive pulmonary disease	0.000111	0.00099	CcSEcCtD
Dipyridamole—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	0.00011	0.00098	CcSEcCtD
Dipyridamole—Pruritus—Montelukast—chronic obstructive pulmonary disease	0.00011	0.000977	CcSEcCtD
Dipyridamole—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	0.000108	0.000964	CcSEcCtD
Dipyridamole—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	0.000108	0.000964	CcSEcCtD
Dipyridamole—Arrhythmia—Prednisolone—chronic obstructive pulmonary disease	0.000108	0.00096	CcSEcCtD
Dipyridamole—Asthenia—Salbutamol—chronic obstructive pulmonary disease	0.000107	0.000955	CcSEcCtD
Dipyridamole—Sweating increased—Prednisone—chronic obstructive pulmonary disease	0.000107	0.00095	CcSEcCtD
Dipyridamole—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	0.000106	0.000945	CcSEcCtD
Dipyridamole—Pruritus—Salbutamol—chronic obstructive pulmonary disease	0.000106	0.000942	CcSEcCtD
Dipyridamole—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.000105	0.000932	CcSEcCtD
Dipyridamole—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.000105	0.000932	CcSEcCtD
Dipyridamole—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.000102	0.000913	CcSEcCtD
Dipyridamole—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	0.000102	0.000911	CcSEcCtD
Dipyridamole—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.000101	0.000896	CcSEcCtD
Dipyridamole—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.000101	0.000896	CcSEcCtD
Dipyridamole—Rash—Arformoterol—chronic obstructive pulmonary disease	9.97e-05	0.000889	CcSEcCtD
Dipyridamole—Rash—Formoterol—chronic obstructive pulmonary disease	9.97e-05	0.000889	CcSEcCtD
Dipyridamole—Dermatitis—Formoterol—chronic obstructive pulmonary disease	9.96e-05	0.000888	CcSEcCtD
Dipyridamole—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	9.96e-05	0.000888	CcSEcCtD
Dipyridamole—Headache—Formoterol—chronic obstructive pulmonary disease	9.9e-05	0.000883	CcSEcCtD
Dipyridamole—Headache—Arformoterol—chronic obstructive pulmonary disease	9.9e-05	0.000883	CcSEcCtD
Dipyridamole—Dizziness—Salbutamol—chronic obstructive pulmonary disease	9.87e-05	0.00088	CcSEcCtD
Dipyridamole—Vomiting—Montelukast—chronic obstructive pulmonary disease	9.85e-05	0.000878	CcSEcCtD
Dipyridamole—Rash—Montelukast—chronic obstructive pulmonary disease	9.76e-05	0.00087	CcSEcCtD
Dipyridamole—Dermatitis—Montelukast—chronic obstructive pulmonary disease	9.75e-05	0.00087	CcSEcCtD
Dipyridamole—Ill-defined disorder—Prednisolone—chronic obstructive pulmonary disease	9.73e-05	0.000868	CcSEcCtD
Dipyridamole—Headache—Montelukast—chronic obstructive pulmonary disease	9.7e-05	0.000865	CcSEcCtD
Dipyridamole—Acute coronary syndrome—Prednisone—chronic obstructive pulmonary disease	9.62e-05	0.000857	CcSEcCtD
Dipyridamole—ABCB1—lung—chronic obstructive pulmonary disease	9.61e-05	0.00161	CbGeAlD
Dipyridamole—Angioedema—Prednisolone—chronic obstructive pulmonary disease	9.59e-05	0.000855	CcSEcCtD
Dipyridamole—Myocardial infarction—Prednisone—chronic obstructive pulmonary disease	9.56e-05	0.000852	CcSEcCtD
Dipyridamole—Vomiting—Salbutamol—chronic obstructive pulmonary disease	9.49e-05	0.000846	CcSEcCtD
Dipyridamole—Malaise—Prednisolone—chronic obstructive pulmonary disease	9.46e-05	0.000843	CcSEcCtD
Dipyridamole—Vertigo—Prednisolone—chronic obstructive pulmonary disease	9.43e-05	0.00084	CcSEcCtD
Dipyridamole—Rash—Salbutamol—chronic obstructive pulmonary disease	9.41e-05	0.000839	CcSEcCtD
Dipyridamole—Syncope—Prednisolone—chronic obstructive pulmonary disease	9.41e-05	0.000839	CcSEcCtD
Dipyridamole—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	9.4e-05	0.000838	CcSEcCtD
Dipyridamole—Nausea—Formoterol—chronic obstructive pulmonary disease	9.39e-05	0.000837	CcSEcCtD
Dipyridamole—Nausea—Arformoterol—chronic obstructive pulmonary disease	9.39e-05	0.000837	CcSEcCtD
Dipyridamole—Headache—Salbutamol—chronic obstructive pulmonary disease	9.35e-05	0.000834	CcSEcCtD
Dipyridamole—Loss of consciousness—Prednisolone—chronic obstructive pulmonary disease	9.22e-05	0.000822	CcSEcCtD
Dipyridamole—Nausea—Montelukast—chronic obstructive pulmonary disease	9.2e-05	0.00082	CcSEcCtD
Dipyridamole—Convulsion—Prednisolone—chronic obstructive pulmonary disease	9.09e-05	0.00081	CcSEcCtD
Dipyridamole—Hypertension—Prednisolone—chronic obstructive pulmonary disease	9.06e-05	0.000807	CcSEcCtD
Dipyridamole—Bradycardia—Prednisone—chronic obstructive pulmonary disease	8.91e-05	0.000795	CcSEcCtD
Dipyridamole—Nausea—Salbutamol—chronic obstructive pulmonary disease	8.87e-05	0.00079	CcSEcCtD
Dipyridamole—Discomfort—Prednisolone—chronic obstructive pulmonary disease	8.82e-05	0.000787	CcSEcCtD
Dipyridamole—Haemoglobin—Prednisone—chronic obstructive pulmonary disease	8.8e-05	0.000785	CcSEcCtD
Dipyridamole—Haemorrhage—Prednisone—chronic obstructive pulmonary disease	8.76e-05	0.000781	CcSEcCtD
Dipyridamole—Anaphylactic shock—Prednisolone—chronic obstructive pulmonary disease	8.56e-05	0.000763	CcSEcCtD
Dipyridamole—Oedema—Prednisolone—chronic obstructive pulmonary disease	8.56e-05	0.000763	CcSEcCtD
Dipyridamole—Shock—Prednisolone—chronic obstructive pulmonary disease	8.42e-05	0.000751	CcSEcCtD
Dipyridamole—Tachycardia—Prednisolone—chronic obstructive pulmonary disease	8.36e-05	0.000745	CcSEcCtD
Dipyridamole—Hyperhidrosis—Prednisolone—chronic obstructive pulmonary disease	8.28e-05	0.000738	CcSEcCtD
Dipyridamole—Flushing—Prednisone—chronic obstructive pulmonary disease	8.13e-05	0.000725	CcSEcCtD
Dipyridamole—Angiopathy—Prednisone—chronic obstructive pulmonary disease	7.95e-05	0.000708	CcSEcCtD
Dipyridamole—Immune system disorder—Prednisone—chronic obstructive pulmonary disease	7.91e-05	0.000705	CcSEcCtD
Dipyridamole—Arrhythmia—Prednisone—chronic obstructive pulmonary disease	7.82e-05	0.000697	CcSEcCtD
Dipyridamole—Alopecia—Prednisone—chronic obstructive pulmonary disease	7.74e-05	0.00069	CcSEcCtD
Dipyridamole—Paraesthesia—Prednisolone—chronic obstructive pulmonary disease	7.69e-05	0.000685	CcSEcCtD
Dipyridamole—Pain—Prednisolone—chronic obstructive pulmonary disease	7.32e-05	0.000653	CcSEcCtD
Dipyridamole—Ill-defined disorder—Prednisone—chronic obstructive pulmonary disease	7.07e-05	0.000631	CcSEcCtD
Dipyridamole—Feeling abnormal—Prednisolone—chronic obstructive pulmonary disease	7.06e-05	0.000629	CcSEcCtD
Dipyridamole—Anaemia—Prednisone—chronic obstructive pulmonary disease	7.05e-05	0.000628	CcSEcCtD
Dipyridamole—Angioedema—Prednisone—chronic obstructive pulmonary disease	6.97e-05	0.000621	CcSEcCtD
Dipyridamole—Malaise—Prednisone—chronic obstructive pulmonary disease	6.87e-05	0.000613	CcSEcCtD
Dipyridamole—Vertigo—Prednisone—chronic obstructive pulmonary disease	6.85e-05	0.000611	CcSEcCtD
Dipyridamole—Syncope—Prednisone—chronic obstructive pulmonary disease	6.84e-05	0.000609	CcSEcCtD
Dipyridamole—Urticaria—Prednisolone—chronic obstructive pulmonary disease	6.8e-05	0.000606	CcSEcCtD
Dipyridamole—Loss of consciousness—Prednisone—chronic obstructive pulmonary disease	6.7e-05	0.000597	CcSEcCtD
Dipyridamole—Convulsion—Prednisone—chronic obstructive pulmonary disease	6.6e-05	0.000589	CcSEcCtD
Dipyridamole—Hypertension—Prednisone—chronic obstructive pulmonary disease	6.58e-05	0.000587	CcSEcCtD
Dipyridamole—Arthralgia—Prednisone—chronic obstructive pulmonary disease	6.49e-05	0.000579	CcSEcCtD
Dipyridamole—Myalgia—Prednisone—chronic obstructive pulmonary disease	6.49e-05	0.000579	CcSEcCtD
Dipyridamole—Anxiety—Prednisone—chronic obstructive pulmonary disease	6.47e-05	0.000577	CcSEcCtD
Dipyridamole—Unspecified disorder of skin and subcutaneous tissue—Prednisone—chronic obstructive pulmonary disease	6.45e-05	0.000575	CcSEcCtD
Dipyridamole—Discomfort—Prednisone—chronic obstructive pulmonary disease	6.41e-05	0.000572	CcSEcCtD
Dipyridamole—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	6.31e-05	0.000562	CcSEcCtD
Dipyridamole—Anaphylactic shock—Prednisone—chronic obstructive pulmonary disease	6.22e-05	0.000555	CcSEcCtD
Dipyridamole—Oedema—Prednisone—chronic obstructive pulmonary disease	6.22e-05	0.000555	CcSEcCtD
Dipyridamole—Shock—Prednisone—chronic obstructive pulmonary disease	6.12e-05	0.000546	CcSEcCtD
Dipyridamole—Nervous system disorder—Prednisone—chronic obstructive pulmonary disease	6.1e-05	0.000544	CcSEcCtD
Dipyridamole—Tachycardia—Prednisone—chronic obstructive pulmonary disease	6.07e-05	0.000541	CcSEcCtD
Dipyridamole—Skin disorder—Prednisone—chronic obstructive pulmonary disease	6.04e-05	0.000539	CcSEcCtD
Dipyridamole—Hyperhidrosis—Prednisone—chronic obstructive pulmonary disease	6.01e-05	0.000536	CcSEcCtD
Dipyridamole—Musculoskeletal discomfort—Prednisone—chronic obstructive pulmonary disease	5.67e-05	0.000505	CcSEcCtD
Dipyridamole—Dizziness—Prednisolone—chronic obstructive pulmonary disease	5.66e-05	0.000505	CcSEcCtD
Dipyridamole—Paraesthesia—Prednisone—chronic obstructive pulmonary disease	5.59e-05	0.000498	CcSEcCtD
Dipyridamole—Dyspepsia—Prednisone—chronic obstructive pulmonary disease	5.48e-05	0.000488	CcSEcCtD
Dipyridamole—Rash—Prednisolone—chronic obstructive pulmonary disease	5.4e-05	0.000481	CcSEcCtD
Dipyridamole—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	5.39e-05	0.000481	CcSEcCtD
Dipyridamole—Fatigue—Prednisone—chronic obstructive pulmonary disease	5.36e-05	0.000478	CcSEcCtD
Dipyridamole—Headache—Prednisolone—chronic obstructive pulmonary disease	5.36e-05	0.000478	CcSEcCtD
Dipyridamole—Feeling abnormal—Prednisone—chronic obstructive pulmonary disease	5.13e-05	0.000457	CcSEcCtD
Dipyridamole—Gastrointestinal pain—Prednisone—chronic obstructive pulmonary disease	5.09e-05	0.000454	CcSEcCtD
Dipyridamole—Nausea—Prednisolone—chronic obstructive pulmonary disease	5.09e-05	0.000453	CcSEcCtD
Dipyridamole—Urticaria—Prednisone—chronic obstructive pulmonary disease	4.94e-05	0.000441	CcSEcCtD
Dipyridamole—Abdominal pain—Prednisone—chronic obstructive pulmonary disease	4.92e-05	0.000438	CcSEcCtD
Dipyridamole—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	4.58e-05	0.000409	CcSEcCtD
Dipyridamole—Asthenia—Prednisone—chronic obstructive pulmonary disease	4.46e-05	0.000398	CcSEcCtD
Dipyridamole—Pruritus—Prednisone—chronic obstructive pulmonary disease	4.4e-05	0.000392	CcSEcCtD
Dipyridamole—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	4.26e-05	0.00038	CcSEcCtD
Dipyridamole—Dizziness—Prednisone—chronic obstructive pulmonary disease	4.11e-05	0.000367	CcSEcCtD
Dipyridamole—Vomiting—Prednisone—chronic obstructive pulmonary disease	3.96e-05	0.000353	CcSEcCtD
Dipyridamole—Rash—Prednisone—chronic obstructive pulmonary disease	3.92e-05	0.00035	CcSEcCtD
Dipyridamole—Dermatitis—Prednisone—chronic obstructive pulmonary disease	3.92e-05	0.000349	CcSEcCtD
Dipyridamole—Headache—Prednisone—chronic obstructive pulmonary disease	3.9e-05	0.000347	CcSEcCtD
Dipyridamole—Nausea—Prednisone—chronic obstructive pulmonary disease	3.7e-05	0.000329	CcSEcCtD
Dipyridamole—PDE1A—Immune System—TLR4—chronic obstructive pulmonary disease	1.38e-05	0.000204	CbGpPWpGaD
Dipyridamole—PDE2A—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	1.37e-05	0.000202	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	1.37e-05	0.000202	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—KL—chronic obstructive pulmonary disease	1.36e-05	0.0002	CbGpPWpGaD
Dipyridamole—PDE10A—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	1.35e-05	0.000199	CbGpPWpGaD
Dipyridamole—PDE1C—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	1.34e-05	0.000198	CbGpPWpGaD
Dipyridamole—PDE8B—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	1.34e-05	0.000197	CbGpPWpGaD
Dipyridamole—PDE8A—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	1.34e-05	0.000197	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	1.33e-05	0.000197	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	1.33e-05	0.000197	CbGpPWpGaD
Dipyridamole—PDE1A—Hemostasis—TGFB1—chronic obstructive pulmonary disease	1.33e-05	0.000196	CbGpPWpGaD
Dipyridamole—PDE1B—Disease—ERBB3—chronic obstructive pulmonary disease	1.33e-05	0.000196	CbGpPWpGaD
Dipyridamole—PDE1B—Hemostasis—VEGFA—chronic obstructive pulmonary disease	1.32e-05	0.000196	CbGpPWpGaD
Dipyridamole—ABCC5—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.32e-05	0.000195	CbGpPWpGaD
Dipyridamole—PDE6G—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	1.32e-05	0.000195	CbGpPWpGaD
Dipyridamole—PDE7B—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	1.32e-05	0.000194	CbGpPWpGaD
Dipyridamole—PDE3B—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	1.32e-05	0.000194	CbGpPWpGaD
Dipyridamole—PDE1B—Immune System—CRP—chronic obstructive pulmonary disease	1.32e-05	0.000194	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	1.31e-05	0.000193	CbGpPWpGaD
Dipyridamole—PDE2A—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	1.3e-05	0.000192	CbGpPWpGaD
Dipyridamole—PDE6A—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	1.3e-05	0.000191	CbGpPWpGaD
Dipyridamole—PDE6B—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	1.3e-05	0.000191	CbGpPWpGaD
Dipyridamole—PDE10A—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	1.29e-05	0.00019	CbGpPWpGaD
Dipyridamole—PDE1C—Immune System—EGFR—chronic obstructive pulmonary disease	1.28e-05	0.000189	CbGpPWpGaD
Dipyridamole—PDE1C—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	1.28e-05	0.000189	CbGpPWpGaD
Dipyridamole—PDE3B—Hemostasis—TP53—chronic obstructive pulmonary disease	1.28e-05	0.000189	CbGpPWpGaD
Dipyridamole—PDE6A—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	1.27e-05	0.000187	CbGpPWpGaD
Dipyridamole—PDE6B—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	1.27e-05	0.000187	CbGpPWpGaD
Dipyridamole—PDE6G—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	1.26e-05	0.000186	CbGpPWpGaD
Dipyridamole—ABCC4—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	1.26e-05	0.000186	CbGpPWpGaD
Dipyridamole—PDE1B—Immune System—TLR4—chronic obstructive pulmonary disease	1.26e-05	0.000186	CbGpPWpGaD
Dipyridamole—ABCC5—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.25e-05	0.000185	CbGpPWpGaD
Dipyridamole—PDE7B—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	1.25e-05	0.000185	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	1.25e-05	0.000185	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—KL—chronic obstructive pulmonary disease	1.24e-05	0.000183	CbGpPWpGaD
Dipyridamole—PDE4A—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	1.23e-05	0.000182	CbGpPWpGaD
Dipyridamole—PDE10A—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	1.23e-05	0.000182	CbGpPWpGaD
Dipyridamole—PDE11A—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	1.22e-05	0.000181	CbGpPWpGaD
Dipyridamole—PDE7A—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	1.22e-05	0.000181	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	1.22e-05	0.000181	CbGpPWpGaD
Dipyridamole—PDE1B—Hemostasis—TGFB1—chronic obstructive pulmonary disease	1.22e-05	0.00018	CbGpPWpGaD
Dipyridamole—PDE1A—Disease—NOS2—chronic obstructive pulmonary disease	1.21e-05	0.000179	CbGpPWpGaD
Dipyridamole—ABCC5—Disease—NOS2—chronic obstructive pulmonary disease	1.21e-05	0.000179	CbGpPWpGaD
Dipyridamole—PDE1C—Disease—TGFB1—chronic obstructive pulmonary disease	1.21e-05	0.000178	CbGpPWpGaD
Dipyridamole—PDE8B—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	1.2e-05	0.000177	CbGpPWpGaD
Dipyridamole—PDE8A—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	1.2e-05	0.000177	CbGpPWpGaD
Dipyridamole—PDE3A—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	1.2e-05	0.000177	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	1.2e-05	0.000176	CbGpPWpGaD
Dipyridamole—PDE6G—Disease—TGFB1—chronic obstructive pulmonary disease	1.19e-05	0.000176	CbGpPWpGaD
Dipyridamole—PDE7B—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	1.19e-05	0.000176	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	1.19e-05	0.000176	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	1.19e-05	0.000175	CbGpPWpGaD
Dipyridamole—PDE1C—Disease—EGFR—chronic obstructive pulmonary disease	1.18e-05	0.000175	CbGpPWpGaD
Dipyridamole—PDE1A—Innate Immune System—EGFR—chronic obstructive pulmonary disease	1.17e-05	0.000173	CbGpPWpGaD
Dipyridamole—ADA—Metabolism—ALB—chronic obstructive pulmonary disease	1.17e-05	0.000173	CbGpPWpGaD
Dipyridamole—PDE2A—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	1.17e-05	0.000173	CbGpPWpGaD
Dipyridamole—PDE6G—Disease—EGFR—chronic obstructive pulmonary disease	1.17e-05	0.000173	CbGpPWpGaD
Dipyridamole—PDE11A—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	1.16e-05	0.000172	CbGpPWpGaD
Dipyridamole—PDE7A—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	1.16e-05	0.000172	CbGpPWpGaD
Dipyridamole—PDE3A—Hemostasis—TP53—chronic obstructive pulmonary disease	1.16e-05	0.000172	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	1.14e-05	0.000169	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	1.14e-05	0.000169	CbGpPWpGaD
Dipyridamole—PDE1C—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	1.13e-05	0.000168	CbGpPWpGaD
Dipyridamole—PDE1A—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	1.13e-05	0.000166	CbGpPWpGaD
Dipyridamole—ADA—Metabolism—NOS3—chronic obstructive pulmonary disease	1.12e-05	0.000166	CbGpPWpGaD
Dipyridamole—PDE6G—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	1.12e-05	0.000165	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	1.12e-05	0.000165	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	1.12e-05	0.000165	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	1.11e-05	0.000164	CbGpPWpGaD
Dipyridamole—PDE1B—Disease—NOS2—chronic obstructive pulmonary disease	1.11e-05	0.000163	CbGpPWpGaD
Dipyridamole—PDE11A—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	1.11e-05	0.000163	CbGpPWpGaD
Dipyridamole—PDE7A—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	1.11e-05	0.000163	CbGpPWpGaD
Dipyridamole—PDE8B—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	1.1e-05	0.000163	CbGpPWpGaD
Dipyridamole—PDE8A—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	1.1e-05	0.000163	CbGpPWpGaD
Dipyridamole—PDE1A—Hemostasis—TP53—chronic obstructive pulmonary disease	1.09e-05	0.000162	CbGpPWpGaD
Dipyridamole—PDE10A—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	1.09e-05	0.000161	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	1.09e-05	0.000161	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	1.08e-05	0.00016	CbGpPWpGaD
Dipyridamole—PDE8A—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	1.08e-05	0.000159	CbGpPWpGaD
Dipyridamole—PDE8B—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	1.08e-05	0.000159	CbGpPWpGaD
Dipyridamole—PDE1C—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	1.08e-05	0.000159	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.07e-05	0.000159	CbGpPWpGaD
Dipyridamole—PDE1B—Innate Immune System—EGFR—chronic obstructive pulmonary disease	1.07e-05	0.000158	CbGpPWpGaD
Dipyridamole—PDE2A—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	1.07e-05	0.000158	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	1.07e-05	0.000158	CbGpPWpGaD
Dipyridamole—PDE7B—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	1.07e-05	0.000158	CbGpPWpGaD
Dipyridamole—PDE6A—Signaling Pathways—TP53—chronic obstructive pulmonary disease	1.07e-05	0.000157	CbGpPWpGaD
Dipyridamole—PDE6B—Signaling Pathways—TP53—chronic obstructive pulmonary disease	1.07e-05	0.000157	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—LEP—chronic obstructive pulmonary disease	1.06e-05	0.000157	CbGpPWpGaD
Dipyridamole—PDE2A—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	1.05e-05	0.000155	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—GC—chronic obstructive pulmonary disease	1.04e-05	0.000154	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	1.04e-05	0.000154	CbGpPWpGaD
Dipyridamole—PDE10A—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	1.04e-05	0.000153	CbGpPWpGaD
Dipyridamole—PDE1B—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	1.03e-05	0.000152	CbGpPWpGaD
Dipyridamole—PDE1C—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	1.03e-05	0.000152	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	1.02e-05	0.000151	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	1.02e-05	0.000151	CbGpPWpGaD
Dipyridamole—PDE1A—Disease—SERPINE1—chronic obstructive pulmonary disease	1.02e-05	0.000151	CbGpPWpGaD
Dipyridamole—ABCC5—Disease—SERPINE1—chronic obstructive pulmonary disease	1.02e-05	0.000151	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	1.02e-05	0.00015	CbGpPWpGaD
Dipyridamole—PDE6G—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	1.01e-05	0.00015	CbGpPWpGaD
Dipyridamole—ABCC4—Hemostasis—VEGFA—chronic obstructive pulmonary disease	1e-05	0.000148	CbGpPWpGaD
Dipyridamole—PDE1B—Hemostasis—TP53—chronic obstructive pulmonary disease	1e-05	0.000148	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—LEP—chronic obstructive pulmonary disease	9.95e-06	0.000147	CbGpPWpGaD
Dipyridamole—PDE11A—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	9.94e-06	0.000147	CbGpPWpGaD
Dipyridamole—PDE7A—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	9.94e-06	0.000147	CbGpPWpGaD
Dipyridamole—PDE10A—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	9.87e-06	0.000146	CbGpPWpGaD
Dipyridamole—PDE1C—Immune System—IL6—chronic obstructive pulmonary disease	9.86e-06	0.000146	CbGpPWpGaD
Dipyridamole—PDE7B—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	9.82e-06	0.000145	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	9.79e-06	0.000144	CbGpPWpGaD
Dipyridamole—PDE6A—Signaling Pathways—IL6—chronic obstructive pulmonary disease	9.76e-06	0.000144	CbGpPWpGaD
Dipyridamole—PDE6B—Signaling Pathways—IL6—chronic obstructive pulmonary disease	9.76e-06	0.000144	CbGpPWpGaD
Dipyridamole—ABCC5—Disease—NOS3—chronic obstructive pulmonary disease	9.73e-06	0.000144	CbGpPWpGaD
Dipyridamole—PDE1A—Disease—NOS3—chronic obstructive pulmonary disease	9.73e-06	0.000144	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	9.71e-06	0.000143	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—LEP—chronic obstructive pulmonary disease	9.68e-06	0.000143	CbGpPWpGaD
Dipyridamole—PDE7B—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	9.62e-06	0.000142	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	9.36e-06	0.000138	CbGpPWpGaD
Dipyridamole—PDE1B—Disease—SERPINE1—chronic obstructive pulmonary disease	9.32e-06	0.000138	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	9.3e-06	0.000137	CbGpPWpGaD
Dipyridamole—PDE1C—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	9.22e-06	0.000136	CbGpPWpGaD
Dipyridamole—ABCC4—Hemostasis—TGFB1—chronic obstructive pulmonary disease	9.22e-06	0.000136	CbGpPWpGaD
Dipyridamole—PDE11A—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	9.13e-06	0.000135	CbGpPWpGaD
Dipyridamole—PDE7A—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	9.13e-06	0.000135	CbGpPWpGaD
Dipyridamole—PDE1C—Disease—IL6—chronic obstructive pulmonary disease	9.1e-06	0.000134	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—LEP—chronic obstructive pulmonary disease	9.1e-06	0.000134	CbGpPWpGaD
Dipyridamole—PDE6G—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	9.09e-06	0.000134	CbGpPWpGaD
Dipyridamole—PDE8B—Signaling Pathways—TP53—chronic obstructive pulmonary disease	9.07e-06	0.000134	CbGpPWpGaD
Dipyridamole—PDE8A—Signaling Pathways—TP53—chronic obstructive pulmonary disease	9.07e-06	0.000134	CbGpPWpGaD
Dipyridamole—PDE1A—Innate Immune System—IL6—chronic obstructive pulmonary disease	9.02e-06	0.000133	CbGpPWpGaD
Dipyridamole—PDE6G—Disease—IL6—chronic obstructive pulmonary disease	8.98e-06	0.000133	CbGpPWpGaD
Dipyridamole—PDE1A—Immune System—IL1B—chronic obstructive pulmonary disease	8.97e-06	0.000132	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	8.95e-06	0.000132	CbGpPWpGaD
Dipyridamole—PDE11A—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	8.95e-06	0.000132	CbGpPWpGaD
Dipyridamole—PDE7A—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	8.95e-06	0.000132	CbGpPWpGaD
Dipyridamole—PDE1B—Disease—NOS3—chronic obstructive pulmonary disease	8.9e-06	0.000131	CbGpPWpGaD
Dipyridamole—PDE10A—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	8.86e-06	0.000131	CbGpPWpGaD
Dipyridamole—PDE2A—Signaling Pathways—TP53—chronic obstructive pulmonary disease	8.84e-06	0.00013	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	8.74e-06	0.000129	CbGpPWpGaD
Dipyridamole—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—chronic obstructive pulmonary disease	8.68e-06	0.000128	CbGpPWpGaD
Dipyridamole—ABCC5—Metabolism—ALB—chronic obstructive pulmonary disease	8.52e-06	0.000126	CbGpPWpGaD
Dipyridamole—PDE1C—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	8.46e-06	0.000125	CbGpPWpGaD
Dipyridamole—PDE6G—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	8.35e-06	0.000123	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	8.34e-06	0.000123	CbGpPWpGaD
Dipyridamole—ABCB1—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	8.33e-06	0.000123	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—LEP—chronic obstructive pulmonary disease	8.32e-06	0.000123	CbGpPWpGaD
Dipyridamole—PDE8A—Signaling Pathways—IL6—chronic obstructive pulmonary disease	8.3e-06	0.000123	CbGpPWpGaD
Dipyridamole—PDE8B—Signaling Pathways—IL6—chronic obstructive pulmonary disease	8.3e-06	0.000123	CbGpPWpGaD
Dipyridamole—PDE1C—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	8.3e-06	0.000122	CbGpPWpGaD
Dipyridamole—PDE1B—Innate Immune System—IL6—chronic obstructive pulmonary disease	8.25e-06	0.000122	CbGpPWpGaD
Dipyridamole—PDE1B—Immune System—IL1B—chronic obstructive pulmonary disease	8.2e-06	0.000121	CbGpPWpGaD
Dipyridamole—PDE6G—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	8.18e-06	0.000121	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	8.18e-06	0.000121	CbGpPWpGaD
Dipyridamole—ABCC5—Metabolism—NOS3—chronic obstructive pulmonary disease	8.15e-06	0.00012	CbGpPWpGaD
Dipyridamole—PDE10A—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	8.13e-06	0.00012	CbGpPWpGaD
Dipyridamole—PDE2A—Signaling Pathways—IL6—chronic obstructive pulmonary disease	8.09e-06	0.000119	CbGpPWpGaD
Dipyridamole—PDE7B—Signaling Pathways—TP53—chronic obstructive pulmonary disease	8.08e-06	0.000119	CbGpPWpGaD
Dipyridamole—PDE10A—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	7.98e-06	0.000118	CbGpPWpGaD
Dipyridamole—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—chronic obstructive pulmonary disease	7.97e-06	0.000118	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	7.96e-06	0.000118	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	7.96e-06	0.000117	CbGpPWpGaD
Dipyridamole—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—chronic obstructive pulmonary disease	7.81e-06	0.000115	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	7.81e-06	0.000115	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	7.59e-06	0.000112	CbGpPWpGaD
Dipyridamole—ABCC4—Hemostasis—TP53—chronic obstructive pulmonary disease	7.59e-06	0.000112	CbGpPWpGaD
Dipyridamole—PDE11A—Signaling Pathways—TP53—chronic obstructive pulmonary disease	7.51e-06	0.000111	CbGpPWpGaD
Dipyridamole—PDE7A—Signaling Pathways—TP53—chronic obstructive pulmonary disease	7.51e-06	0.000111	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	7.48e-06	0.00011	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	7.45e-06	0.00011	CbGpPWpGaD
Dipyridamole—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—chronic obstructive pulmonary disease	7.44e-06	0.00011	CbGpPWpGaD
Dipyridamole—PDE7B—Signaling Pathways—IL6—chronic obstructive pulmonary disease	7.4e-06	0.000109	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	7.25e-06	0.000107	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	7.14e-06	0.000105	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	7.06e-06	0.000104	CbGpPWpGaD
Dipyridamole—PDE1C—Signaling Pathways—TP53—chronic obstructive pulmonary disease	6.96e-06	0.000103	CbGpPWpGaD
Dipyridamole—PDE11A—Signaling Pathways—IL6—chronic obstructive pulmonary disease	6.88e-06	0.000102	CbGpPWpGaD
Dipyridamole—PDE7A—Signaling Pathways—IL6—chronic obstructive pulmonary disease	6.88e-06	0.000102	CbGpPWpGaD
Dipyridamole—PDE6G—Signaling Pathways—TP53—chronic obstructive pulmonary disease	6.87e-06	0.000101	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	6.84e-06	0.000101	CbGpPWpGaD
Dipyridamole—PDE1A—Immune System—EGFR—chronic obstructive pulmonary disease	6.84e-06	0.000101	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	6.82e-06	0.000101	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	6.71e-06	9.91e-05	CbGpPWpGaD
Dipyridamole—PDE10A—Signaling Pathways—TP53—chronic obstructive pulmonary disease	6.7e-06	9.89e-05	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	6.61e-06	9.76e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—chronic obstructive pulmonary disease	6.56e-06	9.68e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	6.53e-06	9.64e-05	CbGpPWpGaD
Dipyridamole—ABCC5—Disease—TGFB1—chronic obstructive pulmonary disease	6.44e-06	9.5e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Disease—TGFB1—chronic obstructive pulmonary disease	6.44e-06	9.5e-05	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	6.43e-06	9.49e-05	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	6.39e-06	9.43e-05	CbGpPWpGaD
Dipyridamole—PDE1C—Signaling Pathways—IL6—chronic obstructive pulmonary disease	6.38e-06	9.41e-05	CbGpPWpGaD
Dipyridamole—ABCC5—Disease—EGFR—chronic obstructive pulmonary disease	6.31e-06	9.32e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Disease—EGFR—chronic obstructive pulmonary disease	6.31e-06	9.32e-05	CbGpPWpGaD
Dipyridamole—PDE6G—Signaling Pathways—IL6—chronic obstructive pulmonary disease	6.29e-06	9.29e-05	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	6.29e-06	9.28e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Immune System—EGFR—chronic obstructive pulmonary disease	6.25e-06	9.23e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	6.23e-06	9.2e-05	CbGpPWpGaD
Dipyridamole—PDE10A—Signaling Pathways—IL6—chronic obstructive pulmonary disease	6.13e-06	9.05e-05	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	6.11e-06	9.03e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	6.05e-06	8.93e-05	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	5.98e-06	8.83e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Disease—TGFB1—chronic obstructive pulmonary disease	5.89e-06	8.69e-05	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	5.82e-06	8.59e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Disease—EGFR—chronic obstructive pulmonary disease	5.77e-06	8.52e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	5.75e-06	8.49e-05	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	5.73e-06	8.47e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—GSTT1—chronic obstructive pulmonary disease	5.71e-06	8.42e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—GCLC—chronic obstructive pulmonary disease	5.64e-06	8.33e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	5.53e-06	8.16e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	5.47e-06	8.07e-05	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	5.37e-06	7.93e-05	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	5.26e-06	7.77e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	5.26e-06	7.76e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Immune System—IL6—chronic obstructive pulmonary disease	5.25e-06	7.76e-05	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	5.22e-06	7.71e-05	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	5.16e-06	7.62e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—CTGF—chronic obstructive pulmonary disease	5.15e-06	7.6e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	5e-06	7.38e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	5e-06	7.38e-05	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	4.93e-06	7.28e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	4.91e-06	7.25e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Disease—IL6—chronic obstructive pulmonary disease	4.85e-06	7.16e-05	CbGpPWpGaD
Dipyridamole—ABCC5—Disease—IL6—chronic obstructive pulmonary disease	4.85e-06	7.16e-05	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	4.83e-06	7.13e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Immune System—IL6—chronic obstructive pulmonary disease	4.8e-06	7.09e-05	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	4.79e-06	7.08e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	4.74e-06	7e-05	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	4.7e-06	6.94e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	4.51e-06	6.65e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	4.49e-06	6.63e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Disease—IL6—chronic obstructive pulmonary disease	4.44e-06	6.55e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	4.42e-06	6.52e-05	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—TP53—chronic obstructive pulmonary disease	4.33e-06	6.4e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	4.12e-06	6.09e-05	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—TP53—chronic obstructive pulmonary disease	4.06e-06	5.99e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	4.04e-06	5.97e-05	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—IL6—chronic obstructive pulmonary disease	3.97e-06	5.86e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—GSTP1—chronic obstructive pulmonary disease	3.95e-06	5.84e-05	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—TP53—chronic obstructive pulmonary disease	3.95e-06	5.83e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—HMOX1—chronic obstructive pulmonary disease	3.9e-06	5.76e-05	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—IL6—chronic obstructive pulmonary disease	3.71e-06	5.48e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—TP53—chronic obstructive pulmonary disease	3.71e-06	5.48e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—GSTM1—chronic obstructive pulmonary disease	3.63e-06	5.37e-05	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—IL6—chronic obstructive pulmonary disease	3.61e-06	5.33e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	3.45e-06	5.09e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—IL6—chronic obstructive pulmonary disease	3.4e-06	5.01e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—TP53—chronic obstructive pulmonary disease	3.39e-06	5.01e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—IL6—chronic obstructive pulmonary disease	3.11e-06	4.59e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—ALB—chronic obstructive pulmonary disease	2.34e-06	3.46e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—NOS3—chronic obstructive pulmonary disease	2.24e-06	3.31e-05	CbGpPWpGaD
